Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kronos Capital Partners is a Toronto-based independent investment bank and strategic advisory firm rather than a drug developer. The firm advises public and founder-owned companies on M&A and capital solutions, with stated sector coverage spanning healthcare, consumer health, and life sciences enabling platforms. Its website also highlights work with cash-pay consumer health and wellness businesses, including capital raises, recapitalizations, sale processes, and acquisition financing. Based on available public information, Kronos Capital Partners appears to be an active private advisory business with healthcare exposure, but it does not appear to operate a therapeutic pipeline or proprietary drug platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kronos Capital Partners.